HIV Articles
Back
 
Cabotegravir for PrEP -083, 084 recent data
CROI:
Laboratory Analysis of HIV Infections in HPTN 083: Injectable CAB for PrEP
- (03/26/21)
CROI:
WEEK 96 EFFICACY AND SAFETY OF CABOTEGRAVIR + RILPIVIRINE EVERY 2 MONTHS: ATLAS-2M
- (03/11/21)
Long acting injectable cabotegravir is safe and effective in preventing HIV infection in cisgender women: results from HPTN 084
ViiV Healthcare announces investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women
- (11/09/20)
View Older Articles
Back to Top
www.natap.org